← SynDRA
BEXAGLIFLOZIN
SynDRA canonical compound SYN0027491 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC5A2 |
|---|
| Mechanism of action | solute carrier family member inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SLC5A2 INHIBITOR
- Sodium/glucose cotransporter 2 inhibitor
- SLC5A1 INHIBITOR
- solute carrier family member inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AURKA
- BRD4
- BRPF1
- CDK2
- CSNK1D
- FGFR2
- GSK3B
- MAPK1
- TRIM24
Drug classes
- Hypoglycemic Agents
- Sodium-Glucose Transporter 2 Inhibitors
- Sodium-Glucose Cotransporter 2 Inhibitor
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- BRENZAVVY
- Bexacat
- Brenzavvy
- brenzavvy
- EGT0001442
- EGT1442
- THR1442
- THR-1442
- Bexagliflozine
- Bexagliflozina
- EGT-0001442
- EGT-1442
- UNII-EY00JF42FV
- Bexagliflozin [USAN]
- EY00JF42FV
- CHEMBL1808388
- Bexagliflozin (USAN)
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropylo
- EGT 1442
- THR 1442
- bexagliflozina
- bexagliflozine
- bexagliflozinum
- bexagliflozin tablets
- RefChem:57074
- MFCD28100944
- Bexagliflozin3
- Brenzavvy (TN)
- Bexgliflozin Impurity 1
- EGT1442; Bexagliflozin
- BEXAGLIFLOZIN [INN]
- Bexgliflozin (EGT1442)
- Bexagliflozin (EGT1442)
- C24H29ClO7
- SCHEMBL302200
- BEXAGLIFLOZIN [WHO-DD]
- SCHEMBL29456628
- GTPL12335
Look up BEXAGLIFLOZIN in the interactive SynDRA portal →